• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Naturvetenskap och teknik
    2. Matematik och naturvetenskap
    3. Biologi
    4. Biokemi

    Human Microbiome in Health and Disease - Part A

    AvBhabatosh Das,Vijai Singh

    Inbunden, Engelska, 2022

    Del 191 i serien Progress in Molecular Biology and Translational Science

    1 824 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Human Microbiome in Health and Disease, Volume 191, Part A presents updated knowledge on human microbiome as covered by renowned science faculty across the globe. Chapters in this volume include an introduction to human microbiome, Structure, functions and diversity of healthy human microbiome, Role of human microbiome in cancer, Gut microbiota and gastrointestinal cancer, Dysbiosis of human microbiome and metabolic diseases, Gut microbiome and type 2 diabetes, Gut microbiome and non-alcoholic fatty liver disease, Hepatic drug metabolism and intestinal microbiota, Emerging tools for understanding the human microbiome, and Microbiome therapeutics: Opportunity and challenges, and more.

    These chapters cover the composition, diversity, dynamics and functions of human microbiome in health and disease. This book will form an excellent and informative text on keystone, autochthonous, and exogenous microbiota important for human health in a simple to understand and easy to read format.



    • Covers the structure, functions and diversity of human microbiome in health and disease
    • Includes discussions on drug metabolisms and microbiome based therapeutics
    • Presents emerging tools for understanding the human microbiome

    Produktinformation

    • Utgivningsdatum:2022-09-26
    • Mått:152 x 229 x 24 mm
    • Vikt:590 g
    • Format:Inbunden
    • Språk:Engelska
    • Serie:Progress in Molecular Biology and Translational Science
    • Antal sidor:288
    • Förlag:Elsevier Science
    • ISBN:9780323997867

    Utforska kategorier

    • Biokemi inom Naturvetenskap och teknik
    • Biologi inom Naturvetenskap och teknik

    Mer om författaren

    Prof. Bhabatosh Das is a leading microbiologist and currently serves as a Professor at the BRIC-Translational Health Science and Technology Institute (THSTI), Faridabad. With a distinguished career in microbial genetics and functional genomics, he heads the Functional Genomics Laboratory, where his team focuses on the development of human microbiome-based biotherapeutics for metabolic disorders and strategies to combat extensively drug-resistant (XDR) bacterial infections by re-sensitizing resistant pathogens.Prof. Das holds an M.Tech. in Biotechnology and Biochemical Engineering from the Indian Institute of Technology (IIT), Kharagpur, and earned his Ph.D. in Microbial Genetics from the Indian Institute of Chemical Biology (IICB), Kolkata. He further expanded his research portfolio through postdoctoral training at the CNRS-Institute of Integrative Biology for the Cell, France, where he specialized in microbial genomics and host-pathogen interactions.His scientific contributions have earned national and international recognition. He was elected as a Fellow of the National Academy of Sciences, India, and also a Fellow of the West Bengal Academy of Science and Technology. In acknowledgment of his impactful work, he has been awarded two prestigious international fellowships, including one from the Japan Society for the Promotion of Science (JSPS), funded by the Government of Japan.Prof. Das has an extensive research output, with over 160 peer-reviewed publications, two edited books, and more than nine Indian patents to his credit. His scholarly work spans a range of topics including antimicrobial resistance (AMR), host-microbiome interactions, and functional genomics, and has contributed significantly to shaping the understanding of microbiome-based interventions in health and disease.In recognition of his outstanding research in the life sciences, Prof. Das received the SR-National Bioscience Award for Career Development (2023) from the Department of Biotechnology (DBT), Government of India—one of the highest national honors for scientists in the field of biosciences.His current research focuses on microbial genomics to elucidate the dynamics of antimicrobial resistance and the development of next-generation biotherapeutics. Through translational research, he aims to bridge the gap between fundamental science and clinical application, addressing critical public health challenges such as multidrug resistance and metabolic disorders.Prof. Das continues to inspire the scientific community through his dedication to excellence in research, mentorship, and innovation in translational microbiology and biotechnology.Prof. Vijai Singh is currently serving as Head of the Department of Biosciences, School of Science and Dean (Research & Innovation) at Indrashil University, Rajpur, Mehsana, India. Prior to this, he held the position of Associate Professor in the same department at Indrashil University. He has also served as Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, and in the Department of Biotechnology at the Invertis University, Bareilly, India. Earlier of his career, Prof. Singh worked as a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and at the School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He earned his Ph.D. in Biotechnology in 2009 from the ICAR-National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India. His doctoral research focused on the development of molecular and immunoassays for the diagnosis of Aeromonas hydrophila. Prof. Singh’s research interests lies in the design and construction of novel biosynthetic pathways for production of medically and industrially important biomolecules. His laboratory is also actively engaged in developing CRISPR-Cas systems for gene knock out, knock in, gene regulation and diagnostic. With over 15 years of research and teaching experience, his areas of expertise include synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has an extensive academic record, with over 110 articles, 89 book chapters, 26 books and 3 patents to his credits. Prof. Singh has received number of prestigious awards, including the Bioclues Innovation, Research and Development Award (2023) from the BIOCLUES Society, the Vice Chancellor's Best Research Award (2023) from Indrashil University, and the Agathiyar Chemical Biology Award (2023) from the Society of Chemical and Synthetic Biology. At Indrashil University, he currently serves as chairman of the Board of Study, and is a member of the Academic Council of Indrashil University. He also holds the position of the Member Secretary of the Institutional Biosafety Committee (IBSC) at the university. Dr. Singh is actively involved in national and international scientific advisory roles.

    Innehållsförteckning

    • PrefaceBhabatosh Das and Vijai Singh1. An introduction to human microbiomeBhabatosh Das2. Emerging tools for understanding the human microbiomeTarini Shankar Ghosh and Mrinmoy Das3. Structure, functions, and diversity of the healthy human microbiomeTaruna Ahrodia, Santanu Das, Susmita Bakshi and Bhabatosh Das4. An overview of cancer and the human microbiomeSoumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra and Punit Prasad5. Gut microbiota in gastrointestinal diseasesGargi Bhattacherjee, Khushal Khambhati, Nisarg Gohil, Priyanka Singh, Jigresh Gohil, Bijun Snehi, Rupesh Maurya, Dinh-Toi Chu, Suresh Ramakrishna and Vijai Singh6. Gut dysbiosis and metabolic diseasesPurbita Bandopadhyay and Dipyaman Ganguly7. Gut microbiome and type 2 diabetesSweta Patel, Sriram Seshadri and Sarat Dalai8. Gut microbiome and non-alcoholic fatty liver diseaseAyushi Purohit, Md Jahangir Alam, Bharti Kandiyal, Shalimar, Bhabatosh Das and Sanjay K. Banerjee9. Hepatic drug metabolism and gut microbiomeTanshi Mehrotra and Subir Kumar Maulik10. Microbiome-based therapeutics: Opportunity and challengesArchana Pant and Bhabatosh Das